Immune-modulating peptide
An immune-modulating peptide approved as a medicine in some overseas markets.
It has approved indications and clinical use in some overseas markets. In Australia it is not broadly registered, and the everyday "immune-boost" framing is not an approved use.
Where accessed under supervision, risks are managed by the prescriber. Compounded peptides are subject to tightened TGA rules and quality considerations.
Not broadly ARTG-registered. Where it is accessed in Australia, this is prescriber-led via compounding.
Limited and supervised — accessed, where appropriate, through a prescriber and compounding rather than general supply.
This entry is general information about Thymosin Alpha-1, not a recommendation to use it. We don’t provide dosing, protocols or sourcing. Speak to a registered practitioner.
This is general education, not medical advice. Peptides.au does not sell, supply, recommend or promote any product or clinic. Always speak with a registered Australian health practitioner before making any health decision.